MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202641062039 A) filed by Neurosense Labs Private Limited on May 15, 2026, for A System And Method For Early Screening Of Neurodevelopmental Disorders Using Multimodal Artificial Intelligence.
Inventors include Dr. Alagiri Govindasamy; and Renukadevi Palaniswamy.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: ABSTRACT Title: “A System and Method for Early Screening of Neurodevelopmental Disorders Using Multimodal Artificial Intelligence” The present invention relates to a system and method for early screening of neurodevelopmental disorders in children using multimodal artificial intelligence and mobile-based digital healthcare infrastructure. The invention comprises a mobile application configured to collect multimodal behavioral data including facial video, voice recordings, and handwriting or motor-behavior inputs. Extracted features from each modality are processed using specialized artificial intelligence models trained on clinically validated datasets. The outputs are integrated through a Behavior-Aware Multimodal Fusion Network (BAMFN) employing attention-based mechanisms to generate a unified probabilistic risk score indicative of neurodevelopmental delay or disorder. The system further provides risk stratification, explainable decision-support outputs, referral recommendations, and caregiver guidance. A longitudinal digital-health record repository enables continuous developmental monitoring over time. The invention additionally incorporates quantum communication based cryptographic security mechanisms, including end-to-end encryption and secure cloud storage, for protection of sensitive pediatric healthcare data. The platform is scalable, interoperable, and deployable across healthcare and community settings. Main Illustrative:
Disclaimer: Curated by HT Syndication.
